Polymer micelles containing nanoparticles in non-aqueous solution, methods for their preparation and use

Patent metadata

Field	Value
Publication number	US-10315178-B2
Application number	US-201515519120-A
Country	US
Kind code	B2
Filing date	Oct 13, 2015
Priority date	Oct 13, 2014
Publication date	Jun 11, 2019
Grant date	Jun 11, 2019

Abstract

The present invention relates to a composition, comprising at least one micelle in non-aqueous solution, wherein the micelle encapsules one or more nanoparticles.
Furthermore, the present invention relates to the use of such a composition and to methods for providing such a composition.

First claim

The invention claimed is:

1. A method for providing a composition comprising at least one micelle encapsulating one or more nanoparticle(s) in non-aqueous solution, wherein in a first step the at least one micelle encapsulating the one or more nanoparticle(s) is formed in an aqueous solution where a surface of the at least one micelle encapsulating the one or more nanoparticle(s) is chemically-crosslinked; wherein in a second step the at least one micelle encapsulating the one or more nanoparticle(s) is transferred to a non-aqueous solution where the non-aqueous solution is at least partially miscible with the aqueous solution, has a higher boiling point than the aqueous solution, and does not form azeotropic phases with water; and
wherein the second step further includes a removal of water to provide the composition comprising the at least one micelle encapsulating one or more nanoparticle(s) in the non-aqueous solution.

2. The method of claim 1 , wherein the one or more nanoparticle(s) are luminescent.

3. The method of claim 2 , wherein the one or more nanoparticle(s) comprise semi-conductor nanoparticle(s).

4. The method of claim 3 , wherein the one or more nanoparticle(s) are doped by heavy-metal ions.

5. The method of claim 2 , wherein the one or more nanoparticle(s) comprise a metal nanoparticle or a metal oxide nanoparticle.

6. The method of claim 1 , wherein a material of the one or more nanoparticle(s) is defined by a formula M x N 1-x A y B 1-y , wherein M and N are independently selected from elements from group 8, 9, 10, 11, 12, 13, or 14 of the periodic table, wherein A and B are independently selected from elements from group 10, 11, 15, or 16 from the periodic table, and wherein x and y can be independently varied between 0 and 1.

7. The method of claim 6 , wherein the one or more nanoparticle(s) comprise at least one shell.

8. The method of claim 7 , wherein a material of the at least one shell is defined by a formula O 1 C z D 1-z , wherein O is independently chosen from group 8, 9, 10, 11, 12, 13, or 14 from the periodic table, wherein C and D are independently chosen from group 10, 11, 15, or 16 from the periodic table; and
wherein z independently assumes a value between 0 and 1 under a provision that M x N 1-x A y B 1-y and O 1 C z D 1-z are not identical.

9. The method of claim 1 , wherein the at least one micelle comprises a chemically crosslinked hydrophilic shell or a crosslinked hydrophilic shell obtained by polymerization.

10. The method of claim 1 , wherein one or more micelle forming element(s) for the at least one micelle encapsulating one or more nanoparticle(s) include amphiphilic block co-polymers.

11. The method of claim 10 , wherein the amphiphilic block co-polymers comprise at least two different polymer blocks of different compatibility towards solvents.

12. The method of claim 10 , wherein the amphiphilic block co-polymers are one of linear, branched, star-shaped, or dendritic.

13. The method of claim 1 , wherein the non-aqueous solution is selected from at least one of:
dialkyl sulfoxides, e.g. dimethyl sulfoxide (DMSO);
carboxylic acid amides, e.g. formamide, acetamide, N-methyl formamide, N-methyl acetamide, N,N-dimethyl formamide (DMF), N,N-dimethyl acetamide (DMA), or N-methyl pyrrolidone (NMP);
phosphoric acid amides e.g. hexamethyl phosphoric acid triamide (HMPA);
urea based solvents like 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone (DMPU), 1,3-dimethyl-2-imidazolidinone (DMI), or tetramethyl urea (TEMUR);
1,4-dioxane; higher alkanols, e.g. 1-butanol;
polyols, like ethylene glycol, 1,2-propanediol, 1,3-propanediol, glycerol, 1,2-butanediol, 1,3-butanediol, 1,4-butanediol, 1,2,4-butanetriol, diethylene glycol (DEG);
ethers of polyols, e.g. 2-methoxyethanol, bis-(2-methoxyethyl) ether (diglyme);
esters of polyols, e.g. diacetoxyethane;
carboxylic acids, like formic acid, acetic acid, propanoic acid, lactic acid;
primary, secondary and tertiary amines, diamines or triamines bearing branched, unbranched or cyclic alky groups on the nitrogen atoms and being liquids at ambient temperature;
cyclic or bicylic amines, optionally bearing further heteroatoms, selected from N,O, or S in the ring, like piperidine, N-methyl piperidine, morpholine, N-methyl morpholine;
annelated amidine bases, like 1,5-diazabicyclo(4.3.0)non-5-ene (DBN) or 1,8-diazabicyclo [5.4.0]undec-7-ene (DBU);
optionally alkylated pyridines, e.g. pyridine, all isomers of picoline, lutidine and collidine;
C1-2 nitro alkanes; ionic liquids, e.g. ammonium-based ionic liquids;
imidazolium based ionic liquids like 1-allyl-3-methylimidazolium, 1-benzyl-3-methylimidazolium, 1-butyl-2,3-dimethylimidazolium, 1-butyl-3-methylimidazolium, 1-decyl-3-methylimidazolium, 1,3-didecyl-2-methylimidazolium, 1,3-dimethylimidazolium, 1,2-dimethyl-3-propylimidazolium, 1-dodecyl-3-methylimidazolium, 1-ethyl-2,3-dimethylimidazolium, 1-ethyl-3-methylimidazolium, 1-hexadecyl-3-methylimidazolium, 1-hexyl-3-methylimidazolium, 1-(2-hydroxyethyl)-3-methylimidazolium, 1-methyl-3-octadecylimidazolium, 1-methyl-3-octylimidazolium, 1-methyl-3-propylimidazolium salts, preferably with complex anions like e.g. tetrafluoroborate;
piperidinium-based ionic liquids, like 1-butyl-1-methylpiperidinium, 1-methyl-1-propylpiperidinium;
pyridinium-based ionic liquids, 1-alkyl-2-methylpyridinium, 1-alkyl-3-methylpyridinium, 1-alkyl-4-methylpyridinium, 1-butylpyridinium, 1-propylpyridinium, 1-ethylpyridinium, 1-hexylpyridinium salts, preferably with complex anions like e.g. tetrafluoroborate;
pyrrolidinium-based ionic liquids, e.g. 1-butyl-1-methylpyrrolidinium, 1-ethyl-1-methylpyrrolidinium, 1-methyl-1-propylpyrrolidinium salts, preferably with complex anions, which in combination with the cation renders the ionic liquid water miscible, like e.g. tetrafluoroborate, or mixtures of said solvents.

14. The method of claim 1 , further comprising conjugating the composition comprising the at least one micelle encapsulating one or more nanoparticle(s) in the non-aqueous solution to a biomolecule of a plurality of biomolecules.

15. The method of claim 1 , wherein the removal of water is via distillation at or below atmospheric pressure.

16. The method of claim 1 , wherein the removal of water is via one or more of azeotropic removal of water, diffusion or permeation across porous or non-porous membranes, and chemical drying.

Assignees

• Fraunhofer Ges Forschung
• Foerderung Der Angewandten Forschung E V

Inventors

• Schotten Theo
• Werner Katja
• Ott Carsten
• Niehaus Jan Steffen
• Dieckmann Marieke
• Weller Horst
• Ostermann Johannes
• Hahn Christoph

Classifications

• C08K2003/0806

  Silver · CPC title

• C09B67/0097

  Dye preparations of special physical nature; Tablets, films, extrusion, microcapsules, sheets, pads, bags with dyes · CPC title

• C09K11/883

  with zinc or cadmium · CPC title

• G01N33/5432

  Liposomes or microcapsules · CPC title

• C08K2003/0843

  Cobalt · CPC title